These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. Gianetti E, Russo L, Orlandi F, Chiovato L, Giusti M, Benvenga S, Moleti M, Vermiglio F, Macchia PE, Vitale M, Regalbuto C, Centanni M, Martino E, Vitti P, Tonacchera M. J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794 [Abstract] [Full Text] [Related]
7. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease. Nagayama Y, Eishima K, Hirayu H, Yamashita S, Ashizawa K, Matsuo K, Inoue S, Harakawa S, Morita S, Izumi M. Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371 [Abstract] [Full Text] [Related]
8. Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism. Pyrżak B, Rumińska M, Witkowska-Sędek E, Kucharska A. Front Endocrinol (Lausanne); 2022 Dec; 13():877119. PubMed ID: 35600602 [Abstract] [Full Text] [Related]
9. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease. Choo YK, Yoo WS, Kim DW, Chung HK. Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556 [Abstract] [Full Text] [Related]
10. Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates. Iwaki H, Ohba K, Okada E, Murakoshi T, Kashiwabara Y, Hayashi C, Matsushita A, Sasaki S, Suda T, Oki Y, Gemma R. Eur Thyroid J; 2021 Jul; 10(5):372-381. PubMed ID: 34540707 [Abstract] [Full Text] [Related]
12. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A. Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092 [Abstract] [Full Text] [Related]
16. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Lo JC, Rivkees SA, Chandra M, Gonzalez JR, Korelitz JJ, Kuzniewicz MW. Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892 [Abstract] [Full Text] [Related]
17. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Mortimer RH, Tyack SA, Galligan JP, Perry-Keene DA, Tan YM. Clin Endocrinol (Oxf); 1990 Feb; 32(2):141-52. PubMed ID: 1971773 [Abstract] [Full Text] [Related]
18. Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine. Bliddal S, Rasmussen ÅK, Sundberg K, Brocks V, Skovbo P, Feldt-Rasmussen U. Thyroid; 2011 Jan; 21(1):75-81. PubMed ID: 21162688 [Abstract] [Full Text] [Related]
19. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N. J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704 [Abstract] [Full Text] [Related]
20. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU). Kubota S. Intern Med; 2016 Jun; 55(22):3235-3237. PubMed ID: 27853063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]